# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:DCTH) with a Buy and raises the pri...
Delcath Systems (NASDAQ:DCTH) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.5...
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...
She joins Delcath from insitro where she served as a Chief Technical Operations Officer and was responsible for core research s...
Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic canc...